Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03149822 |
|---|---|
| Brief Title: | Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma |
| First Submitted : | April 28, 2017 |
| First Submitted that Met QC Criteria : | May 10, 2017 |
| First Posted : | May 11, 2017 |
| Last Update Submitted that Met QC Criteria : | March 19, 2021 |
| Last Update Posted : | March 23, 2021 |